Prior Auth Required

0022U - presence or absence of variants and associated therapy(ies) to consider

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicepresence or absence of variants and associated therapy(ies) to consider
Procedure / Service Description

Targeted genomic sequence analysis panel, non-small cell lung neoplasia, DNA and RNA - Targeted genomic sequence analysis panel, non-small cell lung neoplasia, DNA and RNA analysis, 23 genes, interrogation for sequence variants and rearrangements, reported as 0022U presence or absence of variants and associated therapy(ies) to consider Oncology (acute myelogenous leukemia), DNA, genotyping of internal tandem duplication, p.D835, p.I836, using mononuclear cells, reported as detection or non-detection of FLT3

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.